Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of Nateglinide Treatment in Renal Treatment Recipients With Post Transplant Diabetes Mellitus or Impaired Glucose Tolerance

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00319189
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:34:49.195412+00:00
Published At
2006-05-10T00:00:00+00:00
Record Updated At
2006-05-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Renal Transplant Recipients", "Posttransplant Diabetes Mellitus", "Posttransplant Impaired Glucose Tolerance"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2006-05-10"
protocolSection.identificationModule.nctId
"NCT00319189"
protocolSection.identificationModule.officialTitle
"Efficacy and Safety of Nateglinide Treatment in Renal Treatment Recipients With Post Transplant Diabetes Mellitus or Impaired Glucose Tolerance"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Renal Transplant Recipients (protocolSection.conditionsModule.conditions)
  • Posttransplant Diabetes Mellitus (protocolSection.conditionsModule.conditions)
  • Posttransplant Impaired Glucose Tolerance (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.